Prescription Analysis - CKD (Chronic Kidney Disease) Patient on Hemodialysis

1. Tab. Nicardia XL 30 mg - BD

• Why given: Hypertension control in CKD. Calcium channel blockers are a first-line antihypertensive class in CKD. The patient's BP is noted as 140/61 mmHg, confirming ongoing hypertension management. Nifedipine causes peripheral vasodilation and reduces cardiac afterload.

2. Tab. Telvas 40 mg - BD

• Why given: Telmisartan is an ARB that blocks angiotensin II, reducing intraglomerular pressure. In CKD, ARBs are renoprotective - they slow progression of kidney disease, especially in diabetic nephropathy. They also treat hypertension. Given alongside Nicardia for better BP control (often dual antihypertensive therapy is needed in CKD).

3. Tab. Moxilong 0.2 mg - BD

• Why given: A third antihypertensive agent. CKD patients often have resistant hypertension requiring 3 or more drugs. Moxonidine acts on imidazoline receptors in the brainstem to reduce sympathetic outflow and lower BP. It is particularly useful in CKD patients who are fluid-overloaded and sympathetically overactive.

4. Tab. Dytor 40 mg - BD

• Why given: To manage fluid overload and edema, which is a hallmark of CKD. Loop diuretics like torsemide (torasemide) are preferred over furosemide in CKD due to better oral bioavailability. Torsemide also has anti-aldosterone effects. Used for volume control between dialysis sessions - Tietz Textbook notes torsemide may be more efficacious than other loop diuretics for marked fluid accumulation.

5. Inj. Iron Sucrose 500 mg Infusion - Post HD, 2 months

• Why given: CKD patients on hemodialysis have iron deficiency anemia - a near-universal complication. Causes include:
  • Blood loss during dialysis
  • Reduced erythropoietin production by damaged kidneys
  • Iron deficiency from poor absorption
  • IV iron (sucrose form) is given post-dialysis because oral iron is poorly absorbed and poorly tolerated. The course of 2 months repletes iron stores.

6. Inj. Zyrop 10K - Every 10 days

• Why given: The kidneys produce EPO, which stimulates red blood cell production. In CKD, EPO production is severely reduced, causing renal anemia. Zyrop (10,000 IU) given every 10 days provides erythropoiesis-stimulating agent (ESA) therapy to correct anemia. It is given alongside iron sucrose because EPO cannot work without adequate iron stores.

7. Tab. Phoscut 20 mg - BD (likely Phoscut 400/800)

• Why given: CKD patients cannot excrete phosphate efficiently, leading to hyperphosphatemia. Excess phosphate causes:
  • Secondary hyperparathyroidism
  • Renal osteodystrophy (bone disease)
  • Vascular calcification
  • Cardiovascular disease Sevelamer is a non-calcium phosphate binder taken with meals that binds dietary phosphate in the gut and prevents its absorption - Tietz Textbook confirms sevelamer is a preferred oral phosphate binder in dialysis patients.

8. Tab. Megispil 40 mg - OD

• More likely this is Rosuvas/Atorvastatin equivalent for cardiovascular risk reduction, which is very high in CKD/dialysis patients (cardiovascular disease is the #1 cause of death in CKD).

9. Tab. Neurokem NT 75/10

• Why given: Uremic neuropathy and neuropathic pain - a common complication of CKD where accumulated uremic toxins damage peripheral nerves, causing burning, tingling, numbness, and pain in the extremities ("uremic peripheral neuropathy"). Pregabalin reduces nerve hyperexcitability; nortriptyline (TCA) has adjuvant pain and antidepressant effects.

10. Tab. Dolo 650 mg - SOS

• Why given: For pain or fever as needed (SOS = "si opus sit" = if necessary). Paracetamol is the safest analgesic in CKD patients - NSAIDs are contraindicated as they further reduce GFR and worsen kidney damage.

11. Tab. Palmipain - BD

• Why given: For chronic pain management, possibly uremic neuropathy or musculoskeletal pain. PEA is a naturally occurring fatty acid amide with anti-neuroinflammatory properties, often used as an adjunct for neuropathic and chronic pain with minimal renal/hepatic effects - making it suitable for CKD patients.

Summary: Why So Many Drugs?

Disclaimer: This is for educational understanding only. Drug therapy should always be managed by the treating nephrologist.